Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03228004 · ClinicalTrials.gov registry record · Phase 1
Type 1 Diabetes Data Acquisition and Transfer Adherence Study
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
NCT03228004 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 53 participants.
The verdict
NCT03228004, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to determine if training and support, combined with reminders to facilitate glucose data sharing with the diabetes care team in between clinic visits, can improve glycemic outcomes for patients ages 10-17 with type 1 diabetes who have HbA1c levels above target.
Interventions
- BEHAVIORAL Glooko MeterSync
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2017-07-26 |
| Est. Completion | 2019-04-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03228004
The ClinicalTrials.gov registry entry for NCT03228004 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glooko MeterSync is the first listed.
NCT03228004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03228004 about?
NCT03228004 is a clinical study titled "Type 1 Diabetes Data Acquisition and Transfer Adherence Study". The purpose of this pilot study is to determine if training and support, combined with reminders to facilitate glucose data sharing with the diabetes care team in between clinic visits, can improve glycemic outcomes for patients ages 10-17 with type 1 diabetes who have HbA1c levels above target.
What is the current status of trial NCT03228004?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2017-07-26. Estimated completion is 2019-04-08.
What interventions are being tested in trial NCT03228004?
The interventions under investigation include: Glooko MeterSync (BEHAVIORAL).
Who is sponsoring clinical trial NCT03228004?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.